Doesn't matter if someone does it first since as of yet MANF does it better.GDNF bumped it's head through the whole process. An expensive and long process that has saved MANF the same fate,. Only a matter of time before the blood brain barrier experts come seeking the new Gold standard in neurotrophic factors.
Oh and those of you thinking this is a good time to follow the sell before conference tactic, maybe not this time is all i would suggest. Been here longer than most and this is the most mature i have seen this stock. Personaly i an not expecting big news out of the conference. That has little to due with current volume. Validation is comming, for all of us. Buckle up
News 
Market Data 
Discover 
AI
